Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ ®) for Hypophosphatasia

Condition:   Hypophosphatasia Interventions:   Drug: methotrexate;   Drug: rituximab;   Drug: bortezomib;   Drug: IVIg;   Drug: Folic Acid Sponsor:   Alexion Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials